60¢sixtycents

Kalaris Therapeutics IncKLRS

$4.72+0.17 (+3.74%)
NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap
$112M
Micro-cap
-100%
2020 — today
10-Year Price
-100%
2020 — today
52-Week Range
$2.27$10.98
Current $4.72· 28%

Kalaris Therapeutics Inc. operates as a pharmaceutical enterprise. The company's core mission centers on developing innovative cell therapies. These treatments are designed to reactivate the body's inherent immunity against critical, virus-linked diseases, especially in patients with profoundly compromised immune systems.

Valuation in context

P/E ratio
-2.2
N/A
Not meaningful — company is unprofitable
P/B ratio
1.6
Historically cheap
Historically cheap relative to the last 10 years
FCF Yield
-43.8%
Near historic low
Near historic low — last 10 years
Free · No credit card needed

Get alerted when KLRS is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.